Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, provided an informative overview of myeloma during an M-Power Community Workshop in Tampa. Myeloma, a blood cancer, originates in the bone marrow and primarily affects plasma cells responsible for producing antibodies. Patients with myeloma often experience fatigue, pain, and anemia. Dr. Mikhael highlighted the significant advancements in myeloma treatments, including various drug classes, immunomodulatory drugs, and innovative therapies such as CAR T-cell therapy. The M-Power program strives to change the course of myeloma in the African-American community.
#Myeloma #IMFMPOWER
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: [ Ссылка ]
Visit our website at: [ Ссылка ]
Find us online:
Facebook: @myeloma | [ Ссылка ]
Twitter: @IMFMyeloma | [ Ссылка ]
Instagram: @imfmyeloma | [ Ссылка ]
LinkedIn: [ Ссылка ]
Support the IMF | Donate Now! [ Ссылка ]
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
